Optimizing outcomes in depression: focus on antidepressant compliance
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Major depressive disorder is a chronic and recurrent illness that is associated with significant morbidity and mortality. Patients frequently experience recurrent depressive episodes that are of longer duration and increased severity and which are less responsive to treatment than the index episode. Despite the highly prevalent nature of the illness, depression is frequently unrecognized and undertreated. Compliance with antidepressant medication is essential to consolidate treatment response and prevent relapse and recurrence. However, compliance with antidepressant medication is poor. Education of the patient and physician regarding the nature of depression and its treatment is essential for improving patient compliance. Although psychological mechanisms are a major factor affecting patient compliance, speed of onset of action and poor tolerability of antidepressant medication also have a considerable influence on patient compliance. The newer antidepressants, such as selective serotonin reuptake inhibitors, nonselective serotonin-norepinephrine reuptake inhibitors, and the selective norepinephrine reuptake inhibitors, are better tolerated than tricyclic antidepressants, possibly resulting in improved compliance and treatment outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Long-term Outcome of Episodes of Major Depression: Clinical and Public Health Significance
Keller, M. B. (1984) · JAMA · doi:10.1001/jama.252.6.788 · Cited by 295
Self-citationThe compliance with antidepressants in general practice
Maddox, J. C., Levi, M., & Thompson, C. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800108 · Cited by 148 · cited 1×
“Discontinuation rates increased over the study period: 11% discontinued after 1 week, 24% after 2 weeks, 28% after 4 weeks, 32% after 6 weeks, 43% after 8 weeks and 50% after 10 weeks (Maddox et al., 1994).”
Background
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Deep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression
Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., & Sturm, V. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301408 · Cited by 1,027
“This leads to notable side effects that often lead to non-compliance (Keller et al, 2002).”
BackgroundContinuity of antidepressant treatment for adults with depression in the United States
Olfson, M., Marcus, S. C., Tedeschi, M., & Wan, G. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.101 · Cited by 392
Somatic symptoms in depression
Kapfhammer, H.-P. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.2/hpkapfhammer · Cited by 320
Continuity of Antidepressant Treatment for Adults With Depression in the United States
Ballenger, J. C. (2007) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70480-8 · Cited by 313
Metadata
- Authors
- Keller, M. B., Hirschfeld, R. M. A., Demyttenaere, K., & Baldwin, D. S.
- Venue
- International Clinical Psychopharmacology
- Published
- 2002-11
- Volume
- 17
- Issue
- 6
- Pages
- 265-271
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W1970574861
- Cited by
- 142
- References
- 3
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optimizing outcomes in depression: focus on antidepressant compliance. https://app.cochat.ai/papers/10.1097/00004850-200211000-00001
- The paper
- Keller, M. B., Hirschfeld, R. M. A., Demyttenaere, K., & Baldwin, D. S. (2002). Optimizing outcomes in depression: focus on antidepressant compliance. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-200211000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.